LNA Santé (LNA) Q3 2026 TU earnings summary

Executive summary

• 9M operating revenue reached €702.7m, up 8.4% YoY, including 6.7% organic growth; Q3 revenue rose 9.1% to €237.6m.

• 2026 targets confirmed: operating revenue close to €930m excluding external growth, organic growth above 6%, and real estate revenue of €50m.

Financial highlights

• 9M total revenue, including real estate, was €728.8m, up 8.7% YoY; operating revenue growth included a 1.7-point consolidation-scope contribution.

• 9M organic operating revenue growth comprised volume +4.5%, price +1.3% and mix +0.9%.

• Q3 operating revenue was €237.6m, up 9.1% YoY, including 6.0% organic growth.

Outlook and guidance

• 2026 operating revenue target remains close to €930m, excluding external growth, with organic growth above 6%; real estate revenue target is €50m.

• Sector organic growth targets: French Medical and Social Care above 3.5%, French Healthcare above 8%, and International Business above 2%.

• Q4 drivers include improved nursing-home occupancy, full contribution from five acquired homes, new Île-de-France home-hospitalisation centres, Polish inpatient recovery and real estate sales.